News-Blog EN - CANTREAT

Truck

Targeted Information, Honest Support – The CANTREAT Blog

Cancer changes lives—and we are transforming cancer therapy.
Our blog offers current insights into the world of CANTREAT: from medical background and research findings to personal stories and new developments in oncology. Clear, accessible, and always with one goal: to provide hope – and open up new perspectives.

Tyrolean State Prize for Science awarded to Prof. Dr. Andreas Bernkop-Schnürch

18. June 2025

Every year, the province of Tyrol honors a personality from three alternating disciplines who has made outstanding achievements in the field of research and science.

Beitrag in der Tiroler Tageszeitung vom 16.08.2023

Reward for our specialist

18. June 2025

Article in the Tiroler Tageszeitung of August 16th, 2023

CANTREAT – Medical device or pharmaceutical?

18. June 2025

A fundamental distinction is made between medical devices and drugs.

The financial potential of CANTREAT

18. June 2025

According to the European Cancer Information System (ECIS), there were 2.68 million new cancer cases in the EU in 2020 (Austria: 44,294, Germany: 538,140).

Cancer – Numbers and facts

18. June 2025

Cancer is one of the most frightening diagnoses today and the numbers continue to rise!

The USP of the CANTREAT-Method

18. June 2025

“Drug targeting” means the targeted administration of pharmaceuticals, is being investigated by many research institutions worldwide.

Chemotherapy – The status today

18. June 2025

For decades, chemotherapies have mostly been used in the fight against malignant tumors, in addition to radiation therapies and surgical interventions.

Cooperation with the MED-UNI in Innsbruck is working

8. March 2023

Together with the Institute of Pharmacy at the Leopold-Franzens University of Innsbruck, the basis for the two most essential research topics considered as USP is being developed in a project funded by the Province of Tyrol.

Tyrolean State Prize for Science awarded to Prof. Dr. Andreas Bernkop-Schnürch

Reward for our specialist

CANTREAT – Medical device or pharmaceutical?

The financial potential of CANTREAT

Cancer – Numbers and facts

The USP of the CANTREAT-Method

Chemotherapy – The status today

Cooperation with the MED-UNI in Innsbruck is working

Address

Contact

Legal matters

Social Networks